Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-148618
Filing Date
2021-12-10
Accepted
2021-12-10 16:41:04
Documents
2
Group Members
CITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES GROUP LPCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 CM LIFE SCIENCES III INC. tm2135154d1_sc13g.htm SC 13G 132608
2 JOINT FILING AGREEMENT tm2135154d1_ex99-1.htm EX-99.1 7819
  Complete submission text file 0001104659-21-148618.txt   142147
Mailing Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603
Business Address 131 S. DEARBORN ST., 32ND FLOOR CHICAGO IL 60603 312-395-2100
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
CM Life Sciences III Inc. (Subject) CIK: 0001843762 (see all company filings)

EIN.: 861691173 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93138 | Film No.: 211485921
SIC: 2834 Pharmaceutical Preparations